NCT03701659View on ClinicalTrials.gov

TUPKRP Combined With MAB Therapy for LUTS/PCa

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2025

Conditions
Advanced Prostate CancerLower Urinary Tract SymptomsQuality of LifeOverall SurvivalProgression of Prostate Cancer
Interventions
PROCEDURE

Surgery combinate with Endocrine therapy

TUPKRP is abbreviation of transurethral plasma kinetic resection of prostate, which is an effective treatment of bladder outlet obstruction for benign prostate hyperplasia. MAB is abbreviation of Maximal androgen blockade, which is a kind of endocrinotherapy for advanced prostate cancer.

DRUG

Endocrine therapy

MAB is abbreviation of Maximal androgen blockade, which is a kind of endocrine therapy for advanced prostate cancer.

All Listed Sponsors
lead

The Third Xiangya Hospital of Central South University

OTHER